Literature DB >> 10340795

Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG).

M Wakakura1, R Minei-Higa, S Oono, Y Matsui, A Tabuchi, K Kani, K Shikishima, K Kawai, Y Nakao, Y Tazawa, M Kiyosawa, H Abe, N Ohba, K Yago, S Maeda, M Sugita, S Ishikawa.   

Abstract

BACKGROUND: An optic neuritis treatment trial was conducted at 30 clinical centers in Japan using the same protocol. Patient participation was based on: age range of 14-55 years; acute symptoms indicative of unilateral optic neuritis of unknown or demyelinating origin; visual symptoms of 14-day duration or less; relative afferent pupillary defect in affected eye; and normal or swollen optic disc of affected eye. CASES: Initially, 102 patients qualified for participation; baseline data were obtained for analysis from 70 of these patients. Demographic characteristics of Japanese patients with optic neuritis were clarified and compared with those in a US study. OBSERVATIONS: The incidence of ocular or periocular pain and the presence of periventricular plaques were noted to be lower, and the incidence of disc swelling higher, in the Japanese patients, suggesting racial differences in the characteristics of the disease. Such differences may possibly be related to the lower incidence of multiple sclerosis in Japanese patients. The results of visual function tests were virtually the same in both studies. The nonaffected eyes of more than half the patients showed abnormal mean deviation in Humphrey field analysis, as also noted in the US study.
CONCLUSIONS: The baseline clinical features of optic neuritis in the Japanese patients have been defined. Some racial differences in the characteristics of the disease may exist.

Entities:  

Mesh:

Year:  1999        PMID: 10340795     DOI: 10.1016/s0021-5155(98)00072-0

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  34 in total

Review 1.  [Practical significance of critical fusion frequency (CFF). Chronological resolution of the visual system in differential diagnosis].

Authors:  H Baatz; P Raak; D de Ortueta; A Mirshahi; G Scharioth
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

Review 2.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2015-08-14

Review 3.  Corticosteroids for treating optic neuritis.

Authors:  S S Vedula; S Brodney-Folse; R L Gal; R Beck
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Laser speckle flowgraphy for differentiating between nonarteritic ischemic optic neuropathy and anterior optic neuritis.

Authors:  Tomoyuki Maekubo; Hideki Chuman; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2013-05-22       Impact factor: 2.447

5.  Management of optic neuritis.

Authors:  Vimla Menon; Rohit Saxena; Ruby Misra; Swati Phuljhele
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

6.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

7.  Enhanced Depth Imaging of Central Laminar Thickness in Optic Neuropathy: Comparison with Normal Eyes.

Authors:  Suntaree Thitiwichienlert; Hitoshi Ishikawa; Ken Asakawa; Tetsuya Ikeda; Kimiya Shimizu
Journal:  Neuroophthalmology       Date:  2015-06-23

Review 8.  The optic nerve head in acquired optic neuropathies.

Authors:  Evelyn C O'Neill; Helen V Danesh-Meyer; Paul P Connell; Ian A Trounce; Michael A Coote; David A Mackey; Jonathan G Crowston
Journal:  Nat Rev Neurol       Date:  2010-03-09       Impact factor: 42.937

9.  Retinal ganglion cell and axonal loss in optic neuritis: risk factors and visual functions.

Authors:  T H Lee; Y S Ji; S W Park; H Heo
Journal:  Eye (Lond)       Date:  2016-11-18       Impact factor: 3.775

10.  Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.

Authors:  Bonnie Nga Kwan Choy; Alex Lap Ki Ng; Jimmy Shiu Ming Lai
Journal:  Int Ophthalmol       Date:  2017-03-13       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.